Carmell Co. (NASDAQ:CTCX - Get Free Report) rose 10.2% during trading on Friday . The stock traded as high as $3.16 and last traded at $3.09. Approximately 39,856 shares were traded during trading, a decline of 99% from the average daily volume of 3,610,178 shares. The stock had previously closed at $2.80.
Carmell Trading Up 10.2%
The business's fifty day moving average is $0.27 and its 200 day moving average is $0.31.
Institutional Trading of Carmell
A hedge fund recently bought a new stake in Carmell stock. Antara Capital LP acquired a new position in Carmell Co. (NASDAQ:CTCX - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund acquired 100,000 shares of the company's stock, valued at approximately $28,000. Carmell makes up about 0.0% of Antara Capital LP's holdings, making the stock its 10th largest holding. Antara Capital LP owned about 0.48% of Carmell as of its most recent SEC filing. 24.22% of the stock is owned by institutional investors and hedge funds.
About Carmell
(
Get Free Report)
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Carmell, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carmell wasn't on the list.
While Carmell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
